Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 10, 2024
Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosisGianfranco Alicandro, Andrea Gramegna, Federica Bellino, et al.
Pediatric Pulmonology|June 13, 2024
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6-11 years with cystic fibrosis in a real-world settingValeria Daccò, Chiara Rosazza, Alessandra Mariani, et al.
Lung|November 30, 2024
Lung Clearance Index Improves in People with Cystic Fibrosis not Achieving a Clinical Important Difference in Forced Expiratory Volume in One Second After Elexacaftor/Tezacaftor/Ivacaftor TherapyValeria Daccò, Andrea Gramegna, Chiara Rosazza, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 17, 2025
Limited impact of Elexacaftor/Tezacaftor/Ivacaftor on CPET outcomes in an Italian cohort of people with Cystic Fibrosis: reinforcing the essential role of exercise trainingMariangela Retucci, Andrea Gramegna, Simone Gambazza, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 25, 2024
A case of severe pulmonary exacerbation in a young patient with cystic fibrosis in the era of CFTR modulatorsChiara Lanfranchi, Carmela Rizza, Maria Chiara Russo, et al.
Diabetes & Metabolism|August 3, 2023
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetesValeria Grancini, Andrea Gramegna, Laura Zazzeron, et al.
Biomedicines|August 26, 2022
Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance TherapiesGianfranco Alicandro, Valeria Daccò, Lisa Cariani, et al.
Clinical Therapeutics|June 16, 2026
Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery SystemsValeria Grancini, Gianfranco Alicandro, Irene Cogliati, et al.
Pediatric Research|November 14, 2025
Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in children and adolescents with cystic fibrosis and normal spirometryGianfranco Alicandro, Vito Terlizzi, Laura Zazzeron, et al.
Pediatric Nephrology (Berlin, Germany)|December 16, 2003
Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid ProjectGianluigi Ardissino, Sara Testa, Valeria Daccò, et al.
Pageof 6